Abstract
Sorry, not available.
Click the PDF button.
References
Information
Click the PDF button.
Madersbacher S, Alivizatos G, Nordling J, Sanz CR, Emberton M, de la Rosette JJ. EAU 2004 guideline on assessment, therapy and follow-up of men with lower urinary tract symptoms suggestive of benign prostatic obstruction (BPH guideline). Eur Urol 2004; 46: 547-554.
10.1016/j.eururo.2004.07.01615474261McConnell JD, Roehrborn CG, Bautista OM, Andriole GL Jr, Dixon CM, Kusek JW, Lepor H, McVary KT, Nyberg LM Jr, Clarke HS, Crawford ED, Diokno A, Foley JP, Foster HE, Jacobs SC, Kaplan SA, Kreder KJ, Lieber MM, Lucia MS, Miller GJ, Menon M, Milam DF, Ramsdell JW, Schenkman NS, Slawin KM, Smith JA; Medical Therapy of Prostatic Symptoms (MTOPS) Research Group. The long-term effect of doxazosin, finasteride, and combination therapy on the clinical progression of benign prostatic hyperplasia. N Engl J Med 2003; 349: 2387-2398.
10.1056/NEJMoa03065614681504Roehrborn CG, Siami P, Barkin J, Damia˜o R, Major-Walker K, Morrill B, Montorsi F; CombAT Study Group. The effects of dutasteride, tamsulosin and combination therapy on lower urinary tract symptoms in men with benign prostatic hyperplasia and prostatic enlargement: 2-year results from the CombAT study. J Urol 2008; 179: 616 -621.
10.1016/j.juro.2007.09.08418082216- Publisher :The Association of Korean Urologists
- Publisher(Ko) :대한비뇨의학과의사회
- Journal Title :비뇨의학 Urology Digest
- Volume : 1
- No :1
- Pages :12-15